Erosive Esophagitis
📧 Sign up to get email alerts when something new happens for Erosive Esophagitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) [Phase 3]
A Phase 3 trial comparing linaprazan glurate to lansoprazole in participants with erosive esophagitis due to GERD is currently active but no…
-
CLINICAL_TRIALS trial_result · 2026-07-27Clinical Trial Update: Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. [Phase 3]
Phase 3 trial update evaluating maintenance of healing with oral NEXIUM (esomeprazole) in children aged 1 to 11 with erosive esophagitis; st…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. [Phase 3]
A Phase 3 trial in children aged 1 to 11 with erosive esophagitis shows endoscopic evidence that maintenance therapy with oral esomeprazole …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old [Phase 2]
This entry describes a Phase 2 clinical trial evaluating the safety of dexlansoprazole and its ability to heal and maintain healing of erosi…
-
FDA approval · 2026-03-11FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
The FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole) submitted by BJWC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-03-11FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) by Wal-Mart Stores Inc, enabling the store-brand generic prot…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Maintenance of Healing in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) [Phase 3]
A Phase 3 study compares Linaprazan Glurate with Lansoprazole for maintenance of healing in healed erosive esophagitis due to gastroesophage…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets [Phase 1]
Phase 1 bioequivalence study comparing vonoprazan 20 mg film-coated tablets with Voquezna 20 mg vonoprazan tablets has completed.
-
FDA approval · 2025-12-10FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for a generic omeprazole and sodium bicarbonate combination product.
-
FDA approval · 2025-11-12FDA Approved: DEXLANSOPRAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's generic version of Dexlansoprazole via an Original Application (ANDA 219115). The approval ad…
-
FDA approval · 2025-10-15FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Pantoprazole sodium, a generic pantoprazole product.
-
FDA approval · 2025-10-03FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by Amerisource Bergen.
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 study assessing the long-term safety of BLI5100 in patients with gastroesophageal reflux disease (including non-erosive reflux dis…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis [Phase 3]
A Phase 3 study testing the efficacy and safety of BLI5100 in patients with erosive esophagitis has completed.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) [Phase 3]
Phase 3 clinical trial comparing Linaprazan Glurate to Lansoprazole in participants with erosive esophagitis due to gastroesophageal reflux …
-
FDA approval · 2025-08-15FDA Approved: LANSOPRAZOLE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application to market generic lansoprazole.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence [NA]
Real-world clinical trial investigating how adherence to behavioral and dietary changes affects Gastroesophageal Reflux Disease manifestatio…
-
FDA approval · 2025-07-16FDA Approved: FAMOTIDINE — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for famotidine from Sagent Pharmaceuticals, marking the approval of a generic product.
-
FDA approval · 2025-06-02FDA Approved: FAMOTIDINE — Original Application (Lannett Company, Inc.)
FDA approved the original ANDA for famotidine from Lannett Company, Inc., establishing a generic version of famotidine.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
This update describes an ongoing clinical trial to assess the safety of vonoprazan exposure during pregnancy and in offspring, currently rec…
-
FDA approval · 2025-05-16FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Devatis Inc.)
FDA approves Pantoprazole Sodium as an Original Application generic product from Devatis Inc. under ANDA 215074.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Observationa Study is a Prospective and Multi-institutional Observational Study.
Prospective, multi-institutional observational study sponsored by Jeil Pharmaceutical Co., Ltd. focusing on gastroesophageal reflux disease–…
-
FDA approval · 2025-05-07FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for pantoprazole sodium intravenous formulation from Sandoz Inc., expanding the product to include I…
-
FDA label_change · 2025-04-25FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for pantoprazole sodium by Eugia US LLC, resulting in a labeling update for the product.
-
FDA approval · 2025-04-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for esomeprazole magnesium from Aurobindo Pharma Limited, enabling its marketing as a generic drug in …